載入...
Treatment of hepatitis C virus genotype 4 in the DAA era
The recently approved interferon-free DAA (direct antiviral agents) regimens have shown not only to be effective in terms of sustained virological response (SVR) rates (> 90%) but also well tolerated in most hepatitis C virus (HCV) infected patients. Nevertheless HCV genotypes are different and o...
Na minha lista:
| 發表在: | Virol J |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6251143/ https://ncbi.nlm.nih.gov/pubmed/30466446 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12985-018-1094-4 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|